380843-75-4 Bosutinib
Produkt-Name |
Bosutinib |
Englischer Name |
Bosutinib; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; 3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-; SKI-606 |
Molekulare Formel |
C26H29Cl2N5O3 |
Molecular Weight |
530.4462 |
InChI |
InChI=1/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31) |
CAS Registry Number |
380843-75-4 |
Molecular Structure |
|
Dichte |
1.36g/cm3 |
Schmelzpunkt |
116-120℃ |
Siedepunkt |
649.7°C at 760 mmHg |
Brechungsindex |
1.651 |
Flammpunkt |
346.7°C |
Dampfdruck |
9.15E-17mmHg at 25°C |
Gefahrensymbole |
|
Risk Codes |
|
Safety Beschreibung |
|
|